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Abstract
The connection between the action of microbial RNases and Ca2þ-activated Kþ (KCa) channels was investigated in human embryo kidney
cells HEKhSK4 artificially expressing the channels. These channels protected HEKhSK4 cells from apoptosis induced by binase and 5K charge
reversal mutant of RNase Sa. After the first 24 h, potassium current increased without increase in intracellular Ca2þ, and mitochondrial potential
remained high. After 72 h, the concentration of calcium increased and mitochondria lost their potential. Whole-cell recordings of membrane
currents through KCa channels in RNase-treated cells demonstrated a biphasic pattern: initially their activity in cell population increased, peaked
at 24 h, and then gradually decreased. In each individual cell we observed either an increase of the amplitude of KCa current, or a complete
shutdown of the channels. The activity of KCa channels could be restored by removing RNases from the media. Based on this pattern and
especially its timing, we hypothesize that toxic RNases downregulate KCa channels at the level of transcription or translation. Our results indicate
that new anticancer agents could be created on the basis of microbial RNases targeting KCa channels.
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1. Introduction
Cytotoxic ribonucleases (RNases) represent a novel tool in
anticancer therapy. These quite small proteins preferentially
attack malignant cells, trigger apoptotic responses, and inhibit
protein synthesis [1e3]. RNase from oocytes of Rana pipiens
(onconase; commercial trademark of Alfacell Inc., USA)
induces apoptosis of target cells, most likely through the mito-
chondrial pathway initiated by caspase-9 [4]. In patients with
malignant mesothelioma, onconase is one of the few chemo-
therapeutic agents studied so far. It has limited side effects
[5] and has already revealed a potential survival benefit in
a Phase III trial [6]. Bovine seminal (BS) RNase induces apo-
ptosis in ML-2 myeloid cell line and NB-1 and NB-2 neuro-
blastoma cells [7]. Apoptosis induced by BS RNase is
associated with activation of caspase-8 and -9 [8] and coin-
cides with downregulation of Bcl-2 in several carcinoma cell
lines [9]. Because of its high selectivity for malignant cells
of thyroid origin in vitro, BS RNase has been chosen as a treat-
ment of aggressive thyroid cancer [8]. Bacillus intermedius
ribonuclease (binase) induces apoptosis of human lung carci-
noma A549 cells and human myelogenous leukemia K562
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